Urticarial vasculitis in a COVID-19 recovered patient.
作者信息
Nasiri Soheila, Dadkhahfar Sahar, Abasifar Hajar, Mortazavi Nafiseh, Gheisari Mehdi
机构信息
Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Department of Dermatology, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
出版信息
Int J Dermatol. 2020 Oct;59(10):1285-1286. doi: 10.1111/ijd.15112. Epub 2020 Aug 9.
Abstract
摘要
相似文献
1
Urticarial vasculitis in a COVID-19 recovered patient.一名新冠康复患者的荨麻疹性血管炎
Int J Dermatol. 2020 Oct;59(10):1285-1286. doi: 10.1111/ijd.15112. Epub 2020 Aug 9.
2
Urticaria and urticarial vasculitis.荨麻疹和荨麻疹性血管炎。
Compr Ther. 2003 Summer-Fall;29(2-3):146-56. doi: 10.1007/s12019-003-0018-3.
3
Urticarial vasculitis secondary to H1N1 vaccination.甲型H1N1流感疫苗接种继发的荨麻疹性血管炎
Acta Derm Venereol. 2010 Nov;90(6):651-2. doi: 10.2340/00015555-0950.
4
Urticarial Vasculitis.荨麻疹性血管炎。
Immunol Allergy Clin North Am. 2024 Aug;44(3):483-502. doi: 10.1016/j.iac.2024.03.006. Epub 2024 May 19.
5
Urticarial vasculitis.荨麻疹性血管炎
Allergy Asthma Proc. 2007 Jan-Feb;28(1):97-100. doi: 10.2500/aap.2007.28.2972.
6
[Urticarial vasculitis].[荨麻疹性血管炎]
Vestn Dermatol Venerol. 1989(4):59-63.
7
Clinical efficacy of reserpine as "add-on therapy" to antihistamines in patients with recalcitrant chronic idiopathic urticaria and urticarial vasculitis.利血平作为抗组胺药的“附加疗法”用于顽固性慢性特发性荨麻疹和荨麻疹性血管炎患者的临床疗效。
J Dermatol. 2010 Sep;37(9):827-9. doi: 10.1111/j.1346-8138.2010.00881.x.
8
Asymmetrical cutaneous vasculitis following COVID-19 vaccination with unusual eosinophil preponderance.新型冠状病毒肺炎疫苗接种后出现的不对称性皮肤血管炎，伴有异常的嗜酸性粒细胞增多。
Clin Exp Dermatol. 2021 Dec;46(8):1596-1597. doi: 10.1111/ced.14797. Epub 2021 Jul 29.
9
Recurrent optic disc and retinal vasculitis in a patient with drug-induced urticarial vasculitis.药物性荨麻疹性血管炎患者的复发性视盘和视网膜血管炎
Cutan Ocul Toxicol. 2006;25(4):281-5. doi: 10.1080/15569520601013269.
10
Unique Case of Urticarial Skin Eruptions After COVID-19 Vaccination.新冠疫苗接种后出现荨麻疹性皮疹的罕见病例。
Am J Dermatopathol. 2022 Mar 1;44(3):198-200. doi: 10.1097/DAD.0000000000002036.
引用本文的文献
1
Challenging Clinical Therapeutic Approach to Urticarial Vasculitis: A Case Series.荨麻疹性血管炎的挑战性临床治疗方法：病例系列
J Clin Med. 2025 Jun 27;14(13):4580. doi: 10.3390/jcm14134580.
2
Normocomplementemic Urticarial Vasculitis Following Influenza Vaccination: A Case Report and Review of the Literature.流感疫苗接种后补体正常的荨麻疹性血管炎：一例报告及文献复习
Int Med Case Rep J. 2024 Sep 28;17:823-829. doi: 10.2147/IMCRJ.S483023. eCollection 2024.
3
New Onset of Giant Cell Arteritis following ChAdOx1-S (Vaxevria) Vaccine Administration.接种ChAdOx1-S（Vaxevria）疫苗后新发巨细胞动脉炎
Vaccines (Basel). 2023 Feb 13;11(2):434. doi: 10.3390/vaccines11020434.
4
Cutaneous vasculitis: Lessons from COVID-19 and COVID-19 vaccination.皮肤血管炎：来自COVID-19及COVID-19疫苗接种的经验教训
Front Med (Lausanne). 2022 Dec 9;9:1013846. doi: 10.3389/fmed.2022.1013846. eCollection 2022.
5
Do we miss rare adverse events induced by COVID-19 vaccination?我们是否遗漏了由新冠病毒疫苗接种引起的罕见不良事件？
Front Med (Lausanne). 2022 Oct 10;9:933914. doi: 10.3389/fmed.2022.933914. eCollection 2022.
6
Cutaneous vasculitis and vasculopathy in the era of COVID-19 pandemic.新冠疫情时代的皮肤血管炎和血管病
Front Med (Lausanne). 2022 Aug 23;9:996288. doi: 10.3389/fmed.2022.996288. eCollection 2022.
7
Eosinophilic granulomatosis with polyangiitis after COVID-19: A case report.新型冠状病毒肺炎后嗜酸性肉芽肿性多血管炎：一例报告
Respir Med Case Rep. 2022 Jul 14;38:101702. doi: 10.1016/j.rmcr.2022.101702. eCollection 2022.
8
COVID-19 Vasculitis and vasculopathy-Distinct immunopathology emerging from the close juxtaposition of Type II Pneumocytes and Pulmonary Endothelial Cells.COVID-19 血管炎和血管病变-从 II 型肺泡细胞和肺内皮细胞的紧密并置中出现的独特免疫病理学。
Semin Immunopathol. 2022 May;44(3):375-390. doi: 10.1007/s00281-022-00928-6. Epub 2022 Apr 12.
9
New Onset of Autoimmune Diseases Following COVID-19 Diagnosis.新冠病毒感染后自身免疫性疾病的新发病例。
Cells. 2021 Dec 20;10(12):3592. doi: 10.3390/cells10123592.
10
The skin as a critical window in unveiling the pathophysiologic principles of COVID-19.皮肤作为揭示 COVID-19 病理生理原理的关键窗口。
Clin Dermatol. 2021 Nov-Dec;39(6):934-965. doi: 10.1016/j.clindermatol.2021.07.001. Epub 2021 Jul 22.
本文引用的文献
1
Cutaneous manifestations in COVID-19: Lessons learned from current evidence.新型冠状病毒肺炎的皮肤表现：从当前证据中吸取的教训
J Am Acad Dermatol. 2020 Jul;83(1):e57-e60. doi: 10.1016/j.jaad.2020.04.094. Epub 2020 Apr 24.
2
Vascular skin symptoms in COVID-19: a French observational study.新冠病毒病中的血管性皮肤症状：一项法国观察性研究。
J Eur Acad Dermatol Venereol. 2020 Sep;34(9):e451-e452. doi: 10.1111/jdv.16544. Epub 2020 Jul 20.
3
Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases.严重 COVID-19 感染发病机制中的补体相关微血管损伤和血栓形成：五例报告。
Transl Res. 2020 Jun;220:1-13. doi: 10.1016/j.trsl.2020.04.007. Epub 2020 Apr 15.
4
Urticarial eruption in COVID-19 infection.新型冠状病毒肺炎感染中的荨麻疹样皮疹
J Eur Acad Dermatol Venereol. 2020 Jun;34(6):e244-e245. doi: 10.1111/jdv.16472.
5
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
6
The Complement System and C1q in Chronic Hepatitis C Virus Infection and Mixed Cryoglobulinemia.补体系统和 C1q 在慢性丙型肝炎病毒感染和混合性冷球蛋白血症中的作用。
Front Immunol. 2018 May 29;9:1001. doi: 10.3389/fimmu.2018.01001. eCollection 2018.
7
Urticarial vasculitis and hypocomplementemic urticarial vasculitis syndrome.荨麻疹性血管炎和低补体血症性荨麻疹性血管炎综合征
Immunol Allergy Clin North Am. 2004 May;24(2):183-213, vi. doi: 10.1016/j.iac.2004.01.007.
Zotero 插件